Serum Institute applies for trials of another COVID-19 vaccine
PTI, Jan 30, 2021, 4:28 PM IST
Pune: Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said his company has applied to start the trials of another COVID-19 vaccine and that it hopes to launch it by June 2021.
The city-based firm has already produced Covishield vaccine, co-developed by the University of Oxford and British-Swedish company AstraZeneca. The Centre has purchased 11 million doses of Covishield vaccine for the ongoing inoculation drive.
In a tweet, Poonawalla said, “Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!”
The country launched its COVID-19 vaccination drive from January 16 in what Prime Minister Narendra Modi has called the world’s largest inoculation programme with priority to be given to nearly three crore healthcare and frontline workers.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
SC refuses to examine plea to appoint ‘yoga mitra’ instructors in schools
Maha Vikas Aghadi a vehicle sans wheels and brakes: PM Modi
LDF lodges complaint with EC, seeks probe into distribution of food kits in Wayanad
SC dismisses PIL seeking CBI probe into Tirupati laddus row
Salman Khan gets another threat; message sent to Mumbai traffic police helpline
MUST WATCH
Latest Additions
Mangaluru International Airport achieves record passenger & air traffic movement in October 2024
World Bunts Summit to be held in Mumbai on December 7
SC refuses to examine plea to appoint ‘yoga mitra’ instructors in schools
Maha Vikas Aghadi a vehicle sans wheels and brakes: PM Modi
LDF lodges complaint with EC, seeks probe into distribution of food kits in Wayanad
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.